Miss Nathalie Nataren

Miss Nathalie Nataren

Research Assistant

Centre for Cancer Biology

College of Health

Year Citation
2025 Thompson, E. J., Dorward, E. L., Jurrius, K., Nataren, N., Tondl, M., Myo Min, K. K., . . . Bonder, C. S. (2025). Inhibitor of DNA binding-1 is a key regulator of cancer cell vasculogenic mimicry. Molecular Oncology, online(9), 1-20.
DOI Scopus2 WoS2 Europe PMC1
2025 Mokhtar, S. M. A., Nataren, N. J., Evans, D. R., Moore, M., Bradley, S., MacHacaz Palmar, S., . . . Yamada, M. (2025). Molecular and histological evidence for the biocompatibility of PEDOT-coated microneedles in human skin.. Journal Of Materials Chemistry B, 13(22), 6393-6401.
DOI Scopus3 WoS2 Europe PMC2
2023 Nataren, N., Yamada, M., & Prow, T. (2023). Molecular Skin Cancer Diagnosis: Promise and Limitations. Journal of Molecular Diagnostics, 25(1), 17-35.
DOI Scopus16 WoS11 Europe PMC6
2018 Branford, S., Wang, P., Yeung, D. T., Thomson, D., Purins, A., Wadham, C., . . . Hughes, T. P. (2018). Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease. Blood, 132(9), 948-961.
DOI Scopus173 WoS164 Europe PMC146
2016 Barnett, C., Nataren, N., Klingler-Hoffmann, M., Schwarz, Q., Chong, C., Lee, Y., . . . Scott, H. (2016). Ectrodactyly and lethal pulmonary acinar dysplasia associated with homozygous FGFR2 mutations identified by exome sequencing. Human Mutation, 37(9), 955-963.
DOI Scopus33 WoS24 Europe PMC24
2016 Barnett, C. P., Nataren, N. J., Klingler-Hoffmann, M., Schwarz, Q., Chong, C. E., Lee, Y. K., . . . Scott, H. S. (2016). Cover Image, Volume 37, Issue 9. Human Mutation, 37(9), i.
DOI
2015 Gagliardi, L., Nataren, N., Feng, J., Schreiber, A., Hahn, C., Conwell, L., . . . Scott, H. (2015). Allan-Herndon-Dudley syndrome with unusual profound sensorineural hearing loss. American Journal of Medical Genetics, Part A, 167(8), 1872-1876.
DOI Scopus10 WoS10 Europe PMC9

Connect With Me

External Profiles

Other Links